"Impact of US Healthcare Reforms - Implications for the Pharmaceutical Industry" Published

July 1, 2011 - PRLog -- Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014 and Implications for the Pharmaceutical Industry

Summary

GBI Research has released its latest report, 'Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014 and Implications for the Pharmaceutical Industry' that provides key data, information and analysis of the US healthcare reforms and their impact.

This report offers a comprehensive insight into the provisions and the impact of the US healthcare reforms. It provides an overview of the US healthcare system and establishes the need for healthcare reforms in the US. It talks in detail about the major provisions of the US healthcare reforms and briefly discusses their implications. It also offers the timeline for the implementation for the major provisions of the US healthcare reforms. Finally it discusses the impact of the US healthcare reforms on various stakeholders including the US government, the health insurance industry, the pharmaceutical and biotechnology industry, the hospitals and the employers.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/201054_impact_of_us_healthcare...
------------------------------------------------------------

The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts to provide a comprehensive view of the impact of the US healthcare reforms.

Scope

The scope of the report includes -

* Overview of the US healthcare system
* Major provisions of the US healthcare reforms and their impact
* Impact of the US healthcare reforms on stakeholders including the US government, the health insurance industry, the pharmaceutical industry and the employers.

Reasons to buy

The report will enhance your decision making capabilities. It will allow you to -

* Make more informed business decisions from the insightful and in-depth analysis of the US healthcare reforms and their impact on the stakeholders.
* Identify the opportunities and challenges presented by the US healthcare reforms.
* Build effective strategies to launch the pipeline products by identifying potential segments in the US healthcare market.
* Identify the opportunities for collaboration with the participants in the US healthcare system to develop innovative delivery models for enhancement of value for every stakeholder in the value chain


Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Impact of Healthcare Reforms on the Pharmaceutical Industry - Introduction
2.1 GBI Research Report Guidance
3 The US Healthcare System
3.1 Healthcare Facilities and Skilled Manpower
3.1.1 Healthcare Providers
3.1.2 Hospital Beds
3.1.3 Healthcare Professionals
3.2 Manufacturers and Marketers of the Pharmaceutical Products
3.3 Education and Research Institutes
3.4 Healthcare Funding Mechanism
3.4.1 Private Health Insurance Providers
3.4.2 Public Health Insurance Providers
3.4.3 Break Down of National Health Expenditure
3.5 Government and Regulatory Authorities in the Healthcare System
3.5.1 Department of Health and Human Services
3.5.2 The Food and Drug Administration
3.5.3 Centers for Disease Control
3.5.4 Agency for Healthcare Research and Quality
3.5.5 State Department of Health Services
3.5.6 Centers for Medicare and Medicaid Services
3.5.7 State Insurance Commissioners and National Association of Insurance Commissioners
3.6 Types of Healthcare Service
3.6.1 Primary Care
3.6.2 Secondary Care
3.6.3 Tertiary Care
4 The Need for Healthcare Reforms in the US
4.1 Low Overall Performance of the US Healthcare System
4.2 Rising Healthcare Expenditure in the US
4.3 Increase in the Health Insurance Premiums
4.4 Rise in the Contribution of Prescription Drugs to the NHE
5 Major Provisions of the US Healthcare Reforms
5.1 Introduction
5.2 Major Provisions
5.2.1 Health Insurance Reforms
5.2.2 Increased Health Insurance Coverage
5.2.3 Medicaid Drug Rebate Program Reform
5.2.4 Medicare Related Measures
5.2.5 Provisions for Comparative Effectiveness Research
5.2.6 Establishment of the Biosimilar Approval Pathway
5.2.7 Fee from the Healthcare Industry
5.2.8 Tax Related Measures
5.2.9 Provisions that Impact Primary Healthcare
5.2.10 Research-Related Provisions
5.2.11 Provisions Against Fraud and Abuse
5.2.12 Provisions Related to Transparency
6 Timelines for Implementation
7 Analysis of Impact on Major Stakeholders
7.1 The US Government
7.2 Impact on Insurers
7.2.1 Increased Coverage for Health insurance
7.2.2 Impact of Annual Fee
7.2.3 Impact of Medicare Advantage Plan Payment Cuts
7.2.4 Increase in Insurance Premiums
7.2.5 MLR-Based Regulation
7.2.6 Impact on Insurance Brokers and Agents
7.3 Impact on the Pharmaceutical Industry
7.3.1 Pharmaceutical Companies to Gain from Increased Insurance Coverage
7.3.2 Impact of the Annual Fee on the Pharmaceutical Companies
7.3.3 Impact of Closure of the Donut Hole
7.3.4 Impact of Medicaid Price Rebates
7.3.5 Biosimilar Legislation
7.3.6 No Provision for Pay-for-Delay Ban
7.3.7 Increase in the M&A and Licensing Activity
7.3.8 Increase in Outsourcing
7.3.9 Impact of Comparative Effectiveness Research Related Provisions
7.4 Impact on Employers
7.4.1 Small Businesses
7.4.2 Medium and Large Sized Businesses
7.5 Impact on Hospitals
7.6 Impact on Medical Equipment Providers
8 Impact of the US Healthcare Reforms - Appendix
8.1 Market Definitions
8.2 Abbreviations
8.3 Research Methodology
8.3.1 Coverage
8.3.2 Secondary Research

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=2010...

About GBI Research

GBI Research provides industry-leading global business intelligence solutions. Their products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports each year across a wide range of industries. These reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from their expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia.  View more research from GBI Research at http://www.fastmr.com/catalog/publishers.aspx?pubid=1016

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.